228

29 / 29

46 - giugno 2017 - Minuti
tion for sinusitis. Making the diagnosis by history and physical exami-
nation. Ann InternMed. 1992; 117(9):705-710.
13. BergO, CarenfeltC. Analysis of symptoms and clinical signs in the
maxillary sinus empyema. Acta Otolaryngol. 1988;105(3-4):343-349.
14. LindbaekM, Hjortdahl P, Johnsen UL. Use of symptoms, signs,
and blood tests to diagnose acute sinus infections in primary care: com-
parison with computed tomography. FamMed. 1996;28(3):183-188.
15. van den BroekMF, GuddenC, KluijfhoutWP, et al. No evidence
for distinguishing bacterial fromviral acute rhinosinusitis using symptom
duration and purulent rhinorrhea: a systematic review of the evidence
base. Otolaryngol HeadNeck Surg. 2014;150(4):533-537.
16. SlavinRG, Spector SL, Bernstein IL, et al.; American Academy of
Allergy, Asthma and Immunology; AmericanCollege of Allergy, Asthma
and Immunology; Joint Council of Allergy, Asthma and Immunology.
The diagnosis andmanagement of sinusitis: a practice parameter update.
J Allergy Clin Immunol. 2005;116(6):S13-S47.
17. Meltzer EO, Hamilos DL, Hadley JA, et al.; American Academy
of Allergy, Asthma and Immunology; American Academy of Otolaryn-
gic Allergy; American Academy of Otolaryngology—Head and Neck
Surgery; AmericanCollege of Allergy, Asthma and Immunology; Amer-
ican Rhinologic Society. Rhinosinusitis: establishing definitions for
clinical research and patient care. J Allergy Clin Immunol. 2004;114.
18. Hadley JA, Schaefer SD. Clinical evaluation of rhinosinusitis:
historyandphysicalexamination.OtolaryngolHeadNeckSurg.1997;117(3
pt 2):S8-S11.
19. Cornelius RS,Martin J,WippoldFJ II, et al.; AmericanCollege of
Radiology. ACRappropriateness criteria sinonasal disease. J AmColl Ra-
diol. 2013;10(4):241-246.
20. Savolainen S, Pietola M, Kiukaanniemi H, Lappalainen E,
SalminenM,MikkonenP. Anultrasounddevice in the diagnosis of acute
maxillary sinusitis. Acta Otolaryngol Suppl. 1997;529:148-152.
21. Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis andmanage-
ment for the clinician: a synopsis of recent consensus guidelines. Mayo
Clin Proc. 2011;86(5):427-443.
22. Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults
with clinically diagnosed acute rhinosinusitis: a meta-analysis of indi-
vidual patient data. Lancet. 2008;371 (9616):908-914.
23. Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G,
KarageorgopoulosDE. Comparisonof antibioticswithplacebo for treat-
ment of acute sinusitis: a meta-analysis of randomised controlled trials.
Lancet Infect Dis. 2008;8(9):543-552.
24. Lemiengre MB, van Driel ML, Merenstein D, Young J, De Sut-
ter AI. Antibiotics for clinically diagnosed acute rhinosinusitis in adults.
Cochrane Database Syst Rev. 2012;(10):CD006089.
25. Desrosiers M, Evans GA, Keith PK, et al. Canadian clinical practice
guidelines for acute and chronic rhinosinusitis. JOtolaryngolHeadNeck
Surg. 2011;40(suppl 2):S99-S193.
26. Rosenfeld RM, Singer M, Jones S. Systematic review of antimi-
crobial therapy in patients with acute rhinosinusitis. Otolaryngol Head
Neck Surg. 2007;137(3 suppl):S32-S45.
27. Anon JB, JacobsMR, PooleMD, et al.; Sinus AndAllergyHealth
Partnership. Antimicrobial treatment guidelines for acute bacterial rhi-
nosinusitis [published correctionappears inOtolaryngolHeadNeckSurg.
2004; 130(6):794-796]. Otolaryngol Head Neck Surg. 2004;130 (1
suppl):1-45.
28. Karageorgopoulos DE, GiannopoulouKP, Grammatikos AP, Di-
mopoulosG, FalagasME. Fluoroquinolones comparedwithbeta-lactam
antibiotics for the treatment of acute bacterial sinusitis: ameta-analysis of
randomized controlled trials. CMAJ. 2008;178(7):845-854.
29. U.S. Food and Drug Administration. FDA Drug Safety Com-
munication: FDA advises restricting fluoroquinolone antibiotic use for
certain uncomplicated infections; warns about disabling side effects that
canoccur together.
htm. AccessedMay 27, 2016.
30. FalagasME, KarageorgopoulosDE, Grammatikos AP,Matthaiou
DK. Effectiveness and safety of short vs. long duration of antibiotic ther-
apy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br
J Clin Pharmacol. 2009;67(2):161-171.
31. Meltzer EO, Ratner PH,McGrawT.Oral phenylephrineHCl for
nasal congestion in seasonal allergic rhinitis: a randomized, open-label,
placebocontrolled
study. J Allergy Clin Immunol Pract. 2015;3(5):702-708.
32.HaywardG,HeneghanC, PereraR,ThompsonM. Intranasal corti-
costeroids inmanagement of acute sinusitis: a systematic reviewandmeta-
analysis. Ann FamMed. 2012;10(3):241-249.
33. ZalmanoviciTrestioreanu A, Yaphe J. Intranasal steroids for acute
sinusitis. Cochrane Database Syst Rev. 2013;(12): CD005149.
34. Inanli S,OztürkO, KorkmazM,TutkunA, BatmanC.The effects
of topical agents of fluticasone propionate, oxymetazoline, and 3% and
0.9% sodium chloride solutions on mucociliary clearance in the ther-
apy of acute bacterial rhinosinusitis in vivo. Laryngoscope. 2002; 112(2):
320-325.
35. RabagoD, ZgierskaA,MundtM, Barrett B, Bobula J,MaberryR.
Efficacy of daily hypertonic saline nasal irrigation among patients with si-
nusitis: a randomized controlled trial. J Fam Pract. 2002;51(12):1049-
1055.
36. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide
spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin
Immunol. 1993;92(6):812-823.
37. Barlan IB, Erkan E, Bakir M, Berrak S, Bas¸aranMM. Intranasal
budesonide spray as an adjunct tooral antibiotic therapy for acute sinusitis
in children. Ann Allergy Asthma Immunol. 1997;78(6):598-601.
38. Meltzer EO, Charous BL, BusseWW, Zinreich SJ, Lorber RR,
DanzigMR;TheNasonex SinusitisGroup. Added relief in the treatment
of acute recurrent sinusitis with adjunctive mometasone furoate nasal
spray. J Allergy Clin Immunol. 2000;106(4):630-637.
39. Yilmaz G, Varan B, YilmazT, Gürakan B. Intranasal budesonide
spray as an adjunct to oral antibiotic therapy for acute sinusitis in chil-
dren. Eur ArchOtorhinolaryngol. 2000;257(5):256-259.
40. Dolor RJ,Witsell DL, Hellkamp AS,Williams JWJr, Califf RM,
SimelDL; Ceftin andFlonase for Sinusitis (CAFFS) Investigators. Com-
parisonof cefuroximewithorwithout intranasal fluticasone for the treat-
ment of rhinosinusitis. The CAFFSTrial: a randomized controlled trial
[published correction appears in JAMA. 2004;292(14):1686]. JAMA.
2001; 286(24):3097-3105.
41. NayakAS,SettipaneGA,PedinoffA,etal.;NasonexSinusitisGroup.
Effective dose range of mometasone furoate nasal spray in the treatment
of acute rhinosinusitis. AnnAllergyAsthma Immunol. 2002; 89(3): 271-
278.
42. Mltzer EO, Bachert C, Staudinger H.Treating acute rhinosinusi-
tis: comparing efficacy and safety of mometasone furoate nasal spray,
amoxicillin, and placebo. J Allergy Clin Immunol. 2005;116(6):1289-
1295.
43. Williamson IG, Rumsby K, Benge S, et al. Antibiotics and topi-
cal nasal steroid for treatment of acute maxillary sinusitis: a randomized
controlled trial. JAMA.2007;298(21):2487-2496.
44. KeojampaBK,NguyenMH, RyanMW. Effects of buffered saline
solution on nasal mucociliary clearance and nasal airway patency. Oto-
laryngol HeadNeck Surg. 2004;131(5):679-682.
45. Hauptman G, RyanMW. The effect of saline solutions on nasal
patency and mucociliary clearance in rhinosinusitis patients. Otolaryn-
gol HeadNeck Surg.2007;137(5):815-821.
46. King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irri-
gation for acute upper respiratory tract infections. Cochrane Database
Syst Rev. 2015;(4):CD006821.
47. Yoder JS, Straif-Bourgeois S, Roy SL, et al. Primary amebicmenin-
goencephalitis deaths associatedwith sinus irrigationusing contaminated
tap water. Clin Infect Dis. 2012;55(9):e79-e85.
48. Cope JR, Ratard RC, Hill VR, et al. The first association of a pri-
mary amebic meningoencephalitis death with culturable Naegleria
fowleri in tapwater fromaUS treatedpublic drinkingwater system. Clin
Infect Dis. 2015;60(8):e36-e42.
49. Taverner D, Danz C, Economos D. The effects of oral pseu-
doephedrine on nasal patency in the common cold: a double-blind sin-
gle-doseplacebo-controlledtrial.ClinOtolaryngolAlliedSci.1999;24(1):47-
51.
50. CaenenM, Hamels K, Deron P, Clement P. Comparison of de-
congestive capacity of xylometazoline and pseudoephedrine with rhi-
nomanometry andMRI. Rhinology. 2005;43(3):205-209.
51. Braun JJ, Alabert JP, Michel FB, et al. Adjunct effect of loratadine
in the treatment of acute sinusitis inpatientswith allergic rhinitis. Allergy.
1997;52(6):650-655.
52. TurnerJH,RehDD.Incidenceandsurvivalinpatientswithsinonasal
cancer: a historical analysis of population-based data. Head Neck.
2012; 34(6):877-885.
53. Aring AM, ChanMM. Acute rhinosinusitis in adults. Am Fam
Physician. 2011;83(9):1057-1063.